Murata H - Search Results

1

Genomic characterisation of acral melanoma cell lines.

Furney SJ, Turajlic S, Fenwick K, Lambros MB, MacKay A, Ricken G, Mitsopoulos C, Kozarewa I, Hakas J, Zvelebil M, Lord CJ, Ashworth A, Reis-Filho JS, Herlyn M, Murata H, Marais R. Furney SJ, et al. Among authors: murata h. Pigment Cell Melanoma Res. 2012 Jul;25(4):488-92. doi: 10.1111/j.1755-148X.2012.01016.x. Pigment Cell Melanoma Res. 2012. PMID: 22578220

2

Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.

Takata M, Murata H, Saida T. Takata M, et al. Among authors: murata h. Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71. doi: 10.1111/j.1755-148X.2009.00645.x. Epub 2009 Sep 25. Pigment Cell Melanoma Res. 2010. PMID: 19788535 Review.

3

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T. Murata H, et al. Cancer Sci. 2007 Jul;98(7):958-63. doi: 10.1111/j.1349-7006.2007.00496.x. Epub 2007 May 4. Cancer Sci. 2007. PMID: 17488338 Free PMC article.

4

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression.

Lin J, Goto Y, Murata H, Sakaizawa K, Uchiyama A, Saida T, Takata M. Lin J, et al. Among authors: murata h. Br J Cancer. 2011 Feb 1;104(3):464-8. doi: 10.1038/sj.bjc.6606072. Epub 2011 Jan 11. Br J Cancer. 2011. PMID: 21224857 Free PMC article.

5

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.

Ashida A, Takata M, Murata H, Kido K, Saida T. Ashida A, et al. Among authors: murata h. Int J Cancer. 2009 Feb 15;124(4):862-8. doi: 10.1002/ijc.24048. Int J Cancer. 2009. PMID: 19035443 Free article.

6

Constitutive activation of the mitogen-activated protein kinase signaling pathway in acral melanomas.

Takata M, Goto Y, Ichii N, Yamaura M, Murata H, Koga H, Fujimoto A, Saida T. Takata M, et al. Among authors: murata h. J Invest Dermatol. 2005 Aug;125(2):318-22. doi: 10.1111/j.0022-202X.2005.23812.x. J Invest Dermatol. 2005. PMID: 16098043 Free article.

7

Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin.

Hasegawa J, Goto Y, Murata H, Takata M, Saida T, Imokawa G. Hasegawa J, et al. Among authors: murata h. Pigment Cell Melanoma Res. 2008 Dec;21(6):687-99. doi: 10.1111/j.1755-148x.2008.00492.x. Pigment Cell Melanoma Res. 2008. PMID: 19086131

8

Assessment of BRAF and KIT mutations in Japanese melanoma patients.

Ashida A, Uhara H, Kiniwa Y, Oguchi M, Murata H, Goto Y, Uchiyama A, Ogawa E, Hayashi K, Koga H, Okuyama R. Ashida A, et al. Among authors: murata h. J Dermatol Sci. 2012 Jun;66(3):240-2. doi: 10.1016/j.jdermsci.2012.03.005. Epub 2012 Apr 5. J Dermatol Sci. 2012. PMID: 22534474 No abstract available.

9

A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.

Goto Y, Matsuzaki Y, Kurihara S, Shimizu A, Okada T, Yamamoto K, Murata H, Takata M, Aburatani H, Hoon DS, Saida T, Kawakami Y. Goto Y, et al. Among authors: murata h. Cancer Res. 2006 Apr 15;66(8):4443-9. doi: 10.1158/0008-5472.CAN-05-2505. Cancer Res. 2006. PMID: 16618771

10

Artificial Zymogen Based on Protein-Polymer Hybrids.

Murata H, Kapil K, Kaupbayeva B, Russell AJ, Dordick JS, Matyjaszewski K. Murata H, et al. Biomacromolecules. 2024 Oct 18. doi: 10.1021/acs.biomac.4c01079. Online ahead of print. Biomacromolecules. 2024. PMID: 39422524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,608 results

Search Page